Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | P2RX4 | Q99571 | 1/20 | 0.33 |
| ▸ | BCHE | P06276 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3830139 | 0.98 | ALDH1A1 (0.32) | ALDH1A1HPGDSMN1; SMN2P2RX4BCHE | |
| SCHEMBL3830145 | 0.98 | ALDH1A1 (0.32) | ALDH1A1HPGDSMN1; SMN2P2RX4BCHE | |
| SCHEMBL3588715 | 0.79 | MAPK1 (0.35) | SMN1; SMN2TSHR | |
| SCHEMBL27930086 | 0.77 | RAB9A (0.38) | ALDH1A1HPGDSMN1; SMN2P2RX4TSHR | |
| SCHEMBL4771331 | 0.76 | TSHR (0.35) | ALDH1A1SMN1; SMN2TSHR | |
| SCHEMBL4540593 | 0.76 | — | — | |
| SCHEMBL3797610 | 0.75 | — | — | |
| Hydrochloric Acid SCHEMBL4774116 | 0.74 | TSHR (0.34) | ALDH1A1SMN1; SMN2TSHR | |
| SCHEMBL1838102 | 0.74 | PREP (0.37) | ALDH1A1HPGDSMN1; SMN2BCHE | |
| SCHEMBL28856336 | 0.73 | CHRM2 (0.38) | ALDH1A1HPGDSMN1; SMN2BCHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024213877-A1 | PROCESS | OXFORD UNIVERSITY INNOVATION LIMITED (GB) | 2024-10-17 | — | — | WO | disclosed |
| EP-4391135-A1 | NON-AQUEOUS ELECTROLYTE SOLUTION AND LITHIUM BATTERY | Zhangjiagang Guotai-Huarong New Chemical Materials Co., Ltd (CN) | 2024-06-26 | — | — | EP | disclosed |
| CN-107849024-A | With as indoleamine 2, the benzimidazole and imidazopyridine imido of 3 dioxygenase inhibitor activities are for benzamide compound | 吉利德科学公司 | 2018-03-27 | — | — | CN | disclosed |
| CN-101663278-A | Compounds and compositions as modulators of GPR119 activity | IRM LLC | 2010-03-03 | — | — | CN | disclosed |
| EP-1735320-A1 | COMPOUNDS AND METHODS FOR TREATING DYSLIPIDEMIA | ELI LILLY AND COMPANY (US) | 2006-12-27 | — | — | EP | disclosed |
| WO-2005097806-A1 | COMPOUNDS AND METHODS FOR TREATING DYSLIPIDEMIA | ELI LILLY AND COMPANY (US) | 2005-10-20 | — | — | WO | disclosed |